Symbols

BPMC(Delisted)

Blueprint Medicines·NASDAQ

--(--)

BPMC fundamentals

BPMC Q3 2017 Earnings

Blueprint Medicines (BPMC) released its earnings on Oct 31, 2017: revenue was -- (YoY --), beat estimates; EPS was -- (YoY --), met estimates.

Revenue / YoY

EPS / YoY

Report date

Oct 31, 2017

Earnings

EPS

Revenue

Revenue & Expenses

BPMC has released its 2025 Q1 earnings report, with revenue of 149.41M, reflecting a YoY change of 55.45%, and net profit of 496.00K, showing a YoY change of -99.44%. The Sankey diagram below clearly presents BPMC's revenue sources and cost distribution.

Key Indicators

Blueprint Medicines (BPMC) key financial stats and ratios, covering profitability, financial health, and leverage.

Income Statement

Blueprint Medicines (BPMC)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.

Trend

Breakdown

Balance Sheet

Blueprint Medicines (BPMC)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.

Trend

Breakdown

Cash Flow

Blueprint Medicines (BPMC)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.

Trend

Breakdown

Revenue Breakdown

Where does Blueprint Medicines (BPMC) generate its revenue? Explore its key revenue streams and top earning regions.

By Business

Data source:

By Region

Data source:

Dividend

Track Blueprint Medicines (BPMC) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History

Payout Ratio

Dividend Yield

You can ask Aime

No Data